DK173854B1 - 7alfa-Acylthio-9alfa,11alfa-epoxy-20-spirox-4-en-3,21-dioner, fremgangsmåde til deres fremstilling, farmaceutiske præparater med indhold deraf samt deres anvendelse til fremstilling af farmaceutiske præparater - Google Patents

7alfa-Acylthio-9alfa,11alfa-epoxy-20-spirox-4-en-3,21-dioner, fremgangsmåde til deres fremstilling, farmaceutiske præparater med indhold deraf samt deres anvendelse til fremstilling af farmaceutiske præparater Download PDF

Info

Publication number
DK173854B1
DK173854B1 DK198502800A DK280085A DK173854B1 DK 173854 B1 DK173854 B1 DK 173854B1 DK 198502800 A DK198502800 A DK 198502800A DK 280085 A DK280085 A DK 280085A DK 173854 B1 DK173854 B1 DK 173854B1
Authority
DK
Denmark
Prior art keywords
mixture
epoxy
solution
dione
acid
Prior art date
Application number
DK198502800A
Other languages
Danish (da)
English (en)
Other versions
DK280085A (da
DK280085D0 (da
Inventor
Michel Biollaz
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of DK280085D0 publication Critical patent/DK280085D0/da
Publication of DK280085A publication Critical patent/DK280085A/da
Application granted granted Critical
Publication of DK173854B1 publication Critical patent/DK173854B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002Carbocyclic rings fused
    • C07J53/0043 membered carbocyclic rings
    • C07J53/0083 membered carbocyclic rings in position 15/16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • C07J71/0015Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK198502800A 1984-06-21 1985-06-20 7alfa-Acylthio-9alfa,11alfa-epoxy-20-spirox-4-en-3,21-dioner, fremgangsmåde til deres fremstilling, farmaceutiske præparater med indhold deraf samt deres anvendelse til fremstilling af farmaceutiske præparater DK173854B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH300984 1984-06-21
CH300984 1984-06-21
CH464684 1984-09-28
CH464684 1984-09-28

Publications (3)

Publication Number Publication Date
DK280085D0 DK280085D0 (da) 1985-06-20
DK280085A DK280085A (da) 1985-12-22
DK173854B1 true DK173854B1 (da) 2001-12-27

Family

ID=25691934

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198502800A DK173854B1 (da) 1984-06-21 1985-06-20 7alfa-Acylthio-9alfa,11alfa-epoxy-20-spirox-4-en-3,21-dioner, fremgangsmåde til deres fremstilling, farmaceutiske præparater med indhold deraf samt deres anvendelse til fremstilling af farmaceutiske præparater

Country Status (16)

Country Link
US (1) US4670551A (hu)
EP (1) EP0165902B1 (hu)
AR (2) AR242036A1 (hu)
AU (1) AU582754B2 (hu)
CA (1) CA1239388A (hu)
DE (1) DE3569540D1 (hu)
DK (1) DK173854B1 (hu)
ES (2) ES8704967A1 (hu)
FI (1) FI83225C (hu)
GR (1) GR851499B (hu)
HU (1) HU192232B (hu)
IE (1) IE58050B1 (hu)
IL (1) IL75569A (hu)
NO (1) NO165496C (hu)
NZ (1) NZ212492A (hu)
PT (1) PT80663B (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100384866C (zh) 1995-12-11 2008-04-30 G·D·瑟尔公司 制备7α-羧基9,11-环氧甾族化合物的方法和其中使用的中间体以及烯双键环氧化作用的一般方法
EP1223174A3 (en) * 1996-12-11 2005-03-16 G.D. Searle & Co. Processes for preparation of 3-keto-7alpha-alkoxycarbonyl-delta-4,5- steroids and intermediates useful therein
US6887991B1 (en) 1996-12-11 2005-05-03 G. D. Searle & Company Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein
DK0944644T3 (da) * 1996-12-11 2003-02-03 Searle & Co Fremgangsmåde til fremstilling af 3-keto-7-alfa-alkoxycarbonyl-delta-4,5-steroider og mellemprodukter, som er nyttite derfor
WO1999061055A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
AU2002346721A1 (en) 2001-12-12 2003-06-23 Pharmacia Corporation Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists
US7235655B2 (en) 2002-03-22 2007-06-26 Pharmacia & Upjohn Company Processes to prepare eplerenone
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
WO2007025780A2 (en) * 2005-09-02 2007-03-08 Recordati Ireland Limited Aldosterone receptor antagonists
JP2009508494A (ja) 2005-09-16 2009-03-05 ラプトール ファーマシューティカル インコーポレイテッド Crを含むタンパク質に対して特異的な受容体−結合タンパク質(rap)変異体を含む組成物およびその使用
CA2969926C (en) 2009-02-20 2018-05-15 2-Bbb Medicines B.V. Glutathione-based drug delivery system
IL295075A (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3013012A (en) * 1960-12-22 1961-12-12 Searle & Co Alkanoylthio-17alpha-carboxyethyl-17beta-hydroxyandrosten-3-one lactones
US3095412A (en) * 1961-12-19 1963-06-25 Searle & Co 9alpha, 11alpha-epoxy and 11beta-chloro-9alpha-hydroxy 17alpha-(2-carboxyethyl)-17beta-hydroxyandrost-4-en-3-one gamma-lactones and delta1 and delta6 analogs
GB1041534A (en) * 1963-04-24 1966-09-07 Merck & Co Inc 20-spiroxane compounds
DE2652761C2 (de) * 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
FI77669C (fi) * 1983-04-13 1989-04-10 Ciba Geigy Ag 20-spiroxaner och analoger, som innehaoller en oeppen ring e, foerfarande foer deras framstaellning samt dessa innehaollande farmaceutiska preparat.
DE3481707D1 (de) * 1983-08-17 1990-04-26 Schering Ag 7-alpha-substituierte 3-oxo-17alpha-pregn-4-en-21.17-carbolactone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.

Also Published As

Publication number Publication date
EP0165902B1 (de) 1989-04-19
CA1239388A (en) 1988-07-19
NO852501L (no) 1985-12-23
ES8707737A1 (es) 1987-08-16
EP0165902A2 (de) 1985-12-27
AU582754B2 (en) 1989-04-13
HUT38367A (en) 1986-05-28
AR245731A1 (es) 1994-02-28
HU192232B (en) 1987-05-28
AU4397185A (en) 1986-01-02
DE3569540D1 (en) 1989-05-24
GR851499B (hu) 1985-11-25
FI852430A0 (fi) 1985-06-19
PT80663A (en) 1985-07-01
NO165496B (no) 1990-11-12
IE851535L (en) 1985-12-21
FI852430L (fi) 1985-12-22
US4670551A (en) 1987-06-02
ES544387A0 (es) 1987-04-16
FI83225B (fi) 1991-02-28
NZ212492A (en) 1989-02-24
IE58050B1 (en) 1993-06-16
ES557112A0 (es) 1987-08-16
NO165496C (no) 1991-02-20
IL75569A (en) 1989-03-31
DK280085A (da) 1985-12-22
AR242036A1 (es) 1993-02-26
IL75569A0 (en) 1985-10-31
PT80663B (en) 1987-05-08
ES8704967A1 (es) 1987-04-16
FI83225C (fi) 1991-06-10
DK280085D0 (da) 1985-06-20
EP0165902A3 (en) 1986-10-22

Similar Documents

Publication Publication Date Title
DK173854B1 (da) 7alfa-Acylthio-9alfa,11alfa-epoxy-20-spirox-4-en-3,21-dioner, fremgangsmåde til deres fremstilling, farmaceutiske præparater med indhold deraf samt deres anvendelse til fremstilling af farmaceutiske præparater
EP0122232B1 (de) 20-Spiroxane und Analoge mit geöffnetem Ring E, Verfahren zu ihrer Herstellung, sowie pharmazeutische Präparate davon
US4129564A (en) Spirolactones
CELLA et al. Steroidal aldosterone blockers. II1
IE851284L (en) 1,24-dihydroxy-delta(22)-vitamin d3
US4789668A (en) 1α,7α-dithio-substituted spirolactones, processes for their preparation, and their use as medicines
WO2007025780A2 (en) Aldosterone receptor antagonists
JPS59139400A (ja) 抗アルドステロン活性ステロイド誘導体
EP0644891B1 (en) Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use
JPH0212480B2 (hu)
Rosenheim et al. The metabolism of β-sitosterol
JPS59205400A (ja) 20−スピロキサン系ステロイド及びその製造方法並びに該ステロイドを含有する医薬
JPS6044319B2 (ja) 新規なステロイド誘導体の製造法
SU1079177A3 (ru) Способ получени производных стероидспирооксатиазолидинов в виде их стереоизомеров или их смесей или их солей
DE3344057A1 (de) Eine neue lactonverbindung und pharmazeutische zusammensetzungen davon, sowie verfahren zu ihrer herstellung
Shaw et al. Steroidal Thiazenones and Related Compounds1
US3591583A (en) Steroidal lactones
Johns 3-Deoxy-16-haloestra-1, 3, 5 (10)-trienes
BE859336A (fr) Procede de preparation de nouveaux composes steroidiques ayant une fonction oxygene en position 19
CZ583989A3 (cs) Deriváty 5-methyl-19-nor-5Beta-pregn-9-enu a způsobjejich přípravy
JPS5874659A (ja) アミノシクロペンタン,その製法及び薬学的組成物

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK